Coenzyme Q10 Research Study for Parkinson’s Disease Patients

Coenzyme Q10 Research Study for Parkinson’s Disease Patients

IRB H-27250

There is a clinical study of the research medication Coenzyme Q10 (CoQ10) in persons 30 years of age or older who have early stage Parkinson’s disease. The purpose of this research study is to find out whether CoQ can slow the progression of early Parkinson’s Disease.

Those diagnosed with Parkinson’s disease within the last 5 years and are not yet receiving treatment for their symptoms may be eligible. Study doctors will follow participants every four months over a 16-month period.

There is no cost to participate in the study. Persons with early stage Parkinson’s disease who are interested in participating in this study should contact the Boston University Parkinson’s Disease and Movement Disorder Center at 617-638-7737.

Directory|BUMC
August 3, 2009
Primary teaching affiliate
of BU School of Medicine